267 related articles for article (PubMed ID: 9294121)
21. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
Knowles MR; Paradiso AM; Boucher RC
Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
[TBL] [Abstract][Full Text] [Related]
22. A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia.
Fasbender A; Zabner J; Zeiher BG; Welsh MJ
Gene Ther; 1997 Nov; 4(11):1173-80. PubMed ID: 9425440
[TBL] [Abstract][Full Text] [Related]
23. Quantitative fluorescence measurements of chloride secretion in native airway epithelium from CF and non-CF subjects.
Stern M; Munkonge FM; Caplen NJ; Sorgi F; Huang L; Geddes DM; Alton EW
Gene Ther; 1995 Dec; 2(10):766-74. PubMed ID: 8750017
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats.
Zabner J; Petersen DM; Puga AP; Graham SM; Couture LA; Keyes LD; Lukason MJ; St George JA; Gregory RJ; Smith AE
Nat Genet; 1994 Jan; 6(1):75-83. PubMed ID: 7511023
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.
Zabner J; Couture LA; Gregory RJ; Graham SM; Smith AE; Welsh MJ
Cell; 1993 Oct; 75(2):207-16. PubMed ID: 7691415
[TBL] [Abstract][Full Text] [Related]
26. Effect of co-lipids in enhancing cationic lipid-mediated gene transfer in vitro and in vivo.
Fasbender A; Marshall J; Moninger TO; Grunst T; Cheng S; Welsh MJ
Gene Ther; 1997 Jul; 4(7):716-25. PubMed ID: 9282173
[TBL] [Abstract][Full Text] [Related]
27. Histidylated polylysine as a synthetic vector for gene transfer into immortalized cystic fibrosis airway surface and airway gland serous cells.
Fajac I; Allo JC; Souil E; Merten M; Pichon C; Figarella C; Monsigny M; Briand P; Midoux P
J Gene Med; 2000; 2(5):368-78. PubMed ID: 11045431
[TBL] [Abstract][Full Text] [Related]
28. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
[TBL] [Abstract][Full Text] [Related]
29. A second dose of a CFTR cDNA-liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea.
Goddard CA; Ratcliff R; Anderson JR; Glenn E; Brown S; Gill DR; Hyde SC; MacVinish LJ; Huang L; Higgins CF; Cuthbert AW; Evans MJ; Colledge WH
Gene Ther; 1997 Nov; 4(11):1231-6. PubMed ID: 9425447
[TBL] [Abstract][Full Text] [Related]
30. CFTR gene transfer to human cystic fibrosis pancreatic duct cells using a Sendai virus vector.
Rakonczay Z; Hegyi P; Hasegawa M; Inoue M; You J; Iida A; Ignáth I; Alton EW; Griesenbach U; Ovári G; Vág J; Da Paula AC; Crawford RM; Varga G; Amaral MD; Mehta A; Lonovics J; Argent BE; Gray MA
J Cell Physiol; 2008 Feb; 214(2):442-55. PubMed ID: 17654517
[TBL] [Abstract][Full Text] [Related]
31. Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice.
Cmielewski P; Donnelley M; Parsons DW
J Gene Med; 2014; 16(9-10):291-9. PubMed ID: 25130650
[TBL] [Abstract][Full Text] [Related]
32. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.
Hay JG; McElvaney NG; Herena J; Crystal RG
Hum Gene Ther; 1995 Nov; 6(11):1487-96. PubMed ID: 8573621
[TBL] [Abstract][Full Text] [Related]
33. RT-PCR method specific for the detection of transgenic CFTR mRNA in the presence of transgene plasmid DNA and endogenous CFTR mRNA.
Mayall ES; Coutelle C
Gene Ther; 1997 Aug; 4(8):875-8. PubMed ID: 9338018
[TBL] [Abstract][Full Text] [Related]
34. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
35. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.
Liu X; Jiang Q; Mansfield SG; Puttaraju M; Zhang Y; Zhou W; Cohn JA; Garcia-Blanco MA; Mitchell LG; Engelhardt JF
Nat Biotechnol; 2002 Jan; 20(1):47-52. PubMed ID: 11753361
[TBL] [Abstract][Full Text] [Related]
36. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.
Copreni E; Penzo M; Carrabino S; Conese M
Gene Ther; 2004 Oct; 11 Suppl 1():S67-75. PubMed ID: 15454960
[TBL] [Abstract][Full Text] [Related]
37. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
38. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial.
Alton EW; Stern M; Farley R; Jaffe A; Chadwick SL; Phillips J; Davies J; Smith SN; Browning J; Davies MG; Hodson ME; Durham SR; Li D; Jeffery PK; Scallan M; Balfour R; Eastman SJ; Cheng SH; Smith AE; Meeker D; Geddes DM
Lancet; 1999 Mar; 353(9157):947-54. PubMed ID: 10459902
[TBL] [Abstract][Full Text] [Related]
39. Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.
Zhang LN; Karp P; Gerard CJ; Pastor E; Laux D; Munson K; Yan Z; Liu X; Godwin S; Thomas CP; Zabner J; Shi H; Caldwell CW; Peluso R; Carter B; Engelhardt JF
Mol Ther; 2004 Dec; 10(6):990-1002. PubMed ID: 15564131
[TBL] [Abstract][Full Text] [Related]
40. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution.
Konstan MW; Davis PB; Wagener JS; Hilliard KA; Stern RC; Milgram LJ; Kowalczyk TH; Hyatt SL; Fink TL; Gedeon CR; Oette SM; Payne JM; Muhammad O; Ziady AG; Moen RC; Cooper MJ
Hum Gene Ther; 2004 Dec; 15(12):1255-69. PubMed ID: 15684701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
